Exosomes – News and Features

Scientists are working to find a way deliver a specific microRNA species capable of retarding the growth of tumor cells.

Once thought of as cellular debris, extracellular vesicles are now recognized as key messengers that mitigate cell-cell communication.

Neuroscience beyond the bench; link between diabetes and Alzheimer’s; organization of the sensory cortex, and more.

Researchers at the University of North Carolina (UNC) at Chapel Hill have used exosomes- tiny bubbles of protein and fat produced naturally by cells- to bypass the body's defenses and deliver a potent antioxidant directly to the brain to treat Parkinson's disease.

Company further strengthens executive management for next phase of development.

Innovative angles of attack in research that focus on how the human brain protects and repairs itself will help develop treatments for one of the most common, costly, deadly and scientifically frustrating medical conditions worldwide: traumatic brain injury (TBI).

QIAGEN and Tokai Pharmaceuticals to co-develop and commercialize the first regulated CTC-based companion diagnostic to guide treatments in prostate cancer.

Collaboration will support validation for Exosome Diagnostics’ ALK and T790M plasma-based diagnostics planned to launch in 2015.

New study by the Chamber of Industry and Commerce (IHK), the City of Munich and BioM confirms the importance of this sector.

Researchers unravel the mechanisms behind a novel cancer vaccine for brain tumors, paving the way for further development.